Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85

Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916

hiv-proteaseinhibitorsboosted withritonavir dabigatran

increases exposure

Severe Anecdotal

hiv-proteaseinhibitorsboosted withritonavir thrombininhibitors

increases exposure

Severe Anecdotal

hiv-proteaseinhibitorsboostedwith ritonavir dabigatran

increases exposure

Severe Theoretical

hiv-proteaseinhibitorsboostedwith ritonavir thrombininhibitors

increases exposure

Severe Theoretical

hydroxychloroquine penicillamine

increases risk of haematologicaltoxicity

Severe Theoretical

hydroxyzine antiepileptics

increases risk of overheatinganddehydration

Severe Theoretical

hydroxyzine zonisamide

increases risk of overheatinganddehydration

Severe Theoretical

idelalisib acalabrutinib

increases exposure

Severe Study

idelalisib antiarrhythmics

increases exposure

Severe Theoretical

idelalisib antihistamines,non-sedating

increases exposure

Severe Study

idelalisib antipsychotics,secondgeneration

increases exposure

Severe Study

idelalisib benzodiazepines

increases exposure

Severe Study

idelalisib beta

increases exposure

Severe Study

idelalisib cariprazine

increases exposure

Severe Study

idelalisib domperidone

increases exposure

Severe Study

idelalisib eletriptan

increases exposure

Severe Study

idelalisib eplerenone

increases exposure

Severe Study

idelalisib finerenone

increases exposure

Severe Study

idelalisib lercanidipine

increases exposure

Severe Study

idelalisib lomitapide

increases exposure

Severe Study

idelalisib lurasidone

increases exposure

Severe Study

idelalisib mineralocorticoidreceptorantagonists

increases exposure

Severe Study

idelalisib mobocertinib

increases exposure

Severe Study

idelalisib naloxegol

increases exposure

Severe Study

idelalisib phosphodiesterasetype-

increases exposure

Severe Study

idelalisib quetiapine

increases exposure

Severe Study

idelalisib simvastatin

increases exposure

Severe Study

idelalisib sirolimus

increases concentration

Severe Study

idelalisib temsirolimus

increases concentration

Severe Theoretical

idelalisib ticagrelor

increases exposure

Severe Study

idelalisib trastuzumabemtansine

increases exposure

Severe Theoretical

idelalisibvery antiarrhythmics

increases exposure

Severe Study

idelalisibvery dronedarone

increases exposure

Severe Study

imatinib antipsychotics,secondgeneration

increases exposure

Severe Study

intravenousdantrolene calciumchannelblockers

increases risk of acutehyperkalaemiaandcardiovascularcollapse

Severe Anecdotal

intravenousdantrolene diltiazem

increases risk of acutehyperkalaemiaandcardiovascularcollapse

Severe Anecdotal

intravenousdantrolene verapamil

increases risk of acutehyperkalaemiaandcardiovascularcollapse

Severe Anecdotal

ironchelators antiepileptics

decreases absorption

Severe Theoretical

ironchelators fosphenytoin

decreases absorption

Severe Theoretical

ironchelators phenytoin

decreases absorption

Severe Theoretical

ketoconazole rifabutin

increases concentration

Severe Theoretical

ketoconazole rifamycins

increases concentration

Severe Theoretical

lapatinib pazopanib

increases exposure

Severe Study

letermovir antipsychotics,secondgeneration

increases exposure

Severe Study

letermovir dabigatran

decreases concentration

Severe Theoretical

letermovir domperidone

increases exposure

Severe Study

letermovir meglitinides

increases concentration

Severe Theoretical

letermovir repaglinide

increases concentration

Severe Theoretical

letermovir rosuvastatin

increases exposure

Severe Study

letermovir simvastatin

increases exposure

Severe Study

Prev 1 ... 7 8 9 10 11 ... 126 Next

6278 interactions

Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.